437 related articles for article (PubMed ID: 12629092)
61. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
[TBL] [Abstract][Full Text] [Related]
62. Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.
Pacini F; Capezzone M; Elisei R; Ceccarelli C; Taddei D; Pinchera A
J Clin Endocrinol Metab; 2002 Apr; 87(4):1499-501. PubMed ID: 11932271
[TBL] [Abstract][Full Text] [Related]
63. Positive predictive value of detectable stimulated tg during the first year after therapy of thyroid cancer and the value of comparison with Tg-ablation and Tg measured after 24 months.
Valadão MM; Rosário PW; Borges MA; Costa GB; Rezende LL; Padrão EL; Barroso AL; Purisch S
Thyroid; 2006 Nov; 16(11):1145-9. PubMed ID: 17123341
[TBL] [Abstract][Full Text] [Related]
64. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C
Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060
[TBL] [Abstract][Full Text] [Related]
65. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
Giovanella L; Ceriani L; Ghelfo A; Keller F
Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
[TBL] [Abstract][Full Text] [Related]
66. Neck Sonography and Suppressed Thyroglobulin Have High Sensitivity for Identifying Recurrent/Persistent Disease in Patients With Low-risk Thyroid Cancer Treated With Total Thyroidectomy and Radioactive Iodine Ablation, Making Stimulated Thyroglobulin Unnecessary.
Domínguez JM; Nilo F; Contreras T; Carmona R; Droppelmann N; González H; Iturrieta V; Tuttle RM
J Ultrasound Med; 2017 Nov; 36(11):2299-2307. PubMed ID: 28543974
[TBL] [Abstract][Full Text] [Related]
67. [Serum thyroglobulin and whole-body scanning as markers in the follow-up of differentiated thyroid carcinomas].
Degrossi OJ; Rozados IB; Damilano S; Degrossi EB; de Ganino L; Pinkas M; García del Río H; Artagaveytía D
Medicina (B Aires); 1991; 51(4):291-5. PubMed ID: 1821916
[TBL] [Abstract][Full Text] [Related]
68. [Compared to whole body scanning thyroglobulin assay is reliable in the follow-up of thyroidectomized patients with thyroid carcinoma].
van den Bergh JP; Pieters GF; Beex LV; Ross HA; Corstens FH; Smals AG
Ned Tijdschr Geneeskd; 1993 Jul; 137(27):1344-8. PubMed ID: 8350939
[TBL] [Abstract][Full Text] [Related]
69. Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
Kim WG; Yoon JH; Kim WB; Kim TY; Kim EY; Kim JM; Ryu JS; Gong G; Hong SJ; Shong YK
J Clin Endocrinol Metab; 2008 Dec; 93(12):4683-9. PubMed ID: 18812478
[TBL] [Abstract][Full Text] [Related]
70. Serum thyroglobulin measurements with a high sensitivity enzyme-linked immunosorbent assay: is there a clinical benefit in patients with differentiated thyroid carcinoma?
Zöphel K; Wunderlich G; Smith BR
Thyroid; 2003 Sep; 13(9):861-5. PubMed ID: 14588100
[TBL] [Abstract][Full Text] [Related]
71. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
Stevic I; Dembinski TC; Pathak KA; Leslie WD
Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
[TBL] [Abstract][Full Text] [Related]
72. Serum thyroglobulin level measured after thyroxine withdrawal is useful to predict further recurrence in whole body scan-negative papillary thyroid cancer patients after reoperation.
Park DJ; Lim JA; Kim TH; Choi HS; Ahn HY; Lee EK; Lee YJ; Kim KW; Park YJ; Yi KH; Cho BY
Endocr J; 2012; 59(11):1021-30. PubMed ID: 22814366
[TBL] [Abstract][Full Text] [Related]
73. Comparison of thyroglobulin and radioiodine scintigraphy during follow-up of patients with differentiated thyroid carcinoma.
Johansen K; Woodhouse NJ
Eur J Med; 1992 Nov; 1(7):403-6. PubMed ID: 1341479
[TBL] [Abstract][Full Text] [Related]
74. Follow-up of low risk patients with papillary thyroid cancer: role of neck ultrasonography in detecting lymph node metastases.
Torlontano M; Attard M; Crocetti U; Tumino S; Bruno R; Costante G; D'Azzò G; Meringolo D; Ferretti E; Sacco R; Arturi F; Filetti S
J Clin Endocrinol Metab; 2004 Jul; 89(7):3402-7. PubMed ID: 15240622
[TBL] [Abstract][Full Text] [Related]
75. Undetectable serum thyroglobulin levels in patients with medullary thyroid carcinoma after total thyroidectomy without radioiodine ablation.
Tomoda C; Miyauchi A
Thyroid; 2012 Jul; 22(7):680-2. PubMed ID: 22663550
[TBL] [Abstract][Full Text] [Related]
76. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma].
Abduluakhab M; Gavrilov M; Mladenov B
Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856
[TBL] [Abstract][Full Text] [Related]
77. A randomized clinical trial comparing 50mCi and 100mCi of iodine-131 for ablation of differentiated thyroid cancers.
Zaman Mu; Toor R; Kamal S; Maqbool M; Habib S; Niaz K
J Pak Med Assoc; 2006 Aug; 56(8):353-6. PubMed ID: 16967785
[TBL] [Abstract][Full Text] [Related]
78. Stimulated thyroglobulin at recombinant human TSH-aided ablation predicts disease-free status one year later.
Melo M; Costa G; Ribeiro C; Carrilho F; Martins MJ; da Rocha AG; Sobrinho-Simões M; Carvalheiro M; Soares P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4364-72. PubMed ID: 24037891
[TBL] [Abstract][Full Text] [Related]
79. [Outcome of differentiated thyroid cancer after initial treatment].
Konrády A; Bencsik Z; Locsey Z; Bénik T
Orv Hetil; 2011 Oct; 152(43):1731-8. PubMed ID: 21983399
[TBL] [Abstract][Full Text] [Related]
80. A high-sensitivity enzyme-linked immunosorbent assay for serum thyroglobulin.
Wunderlich G; Zöphel K; Crook L; Smith S; Smith BR; Franke WG
Thyroid; 2001 Sep; 11(9):819-24. PubMed ID: 11575850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
